[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357145-105":59,"doc-detail-357145-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stromal-peroxidasin-drives-early-tumor-growth-in-breast-cancer","Stromal Peroxidasin Drives Early Tumor Growth in Breast Cancer","","Extracellular matrix components shape both tumor-promoting and tumor-restraining behavior during breast cancer progression. The study characterizes extracellular peroxidases as a remodeling machinery element and focuses on peroxidasin (PXDN), an ECM enzyme involved in collagen IV crosslinking. Temporal proteomic profiling in mouse models shows PXDN upregulation during early tumor development. In human breast cancers, stromal PXDN, largely derived from cancer-associated fibroblasts (CAFs), links to poor patient prognosis. Functional experiments reveal that CAF-derived PXDN regulates CAF behavior and drives matrix remodeling that alters cancer-cell behavior. In vivo reduction of CAF-derived PXDN slows tumor development, and pharmacological inhibition of extracellular peroxidases improves survival, supporting PXDN as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stromal-peroxidasin-drives-early-tumor-growth-in-breast-cancer/357145/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stromal-peroxidasin-drives-early-tumor-growth-in-breast-cancer/357145.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does peroxidasin (PXDN) play in early breast cancer development?","Question",{"text":112,"@type":113},"Temporal proteomic analysis shows PXDN is upregulated during early tumor development in mouse models, indicating a role in initiating stromal changes that support tumor growth.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is PXDN linked to prognosis in human breast cancer?",{"text":117,"@type":113},"Human data show compartment-specific associations, with high stromal PXDN—predominantly derived from cancer-associated fibroblasts—correlating with poor prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategies did the study test targeting PXDN-related pathways?",{"text":121,"@type":113},"The study reduced CAF-derived PXDN in vivo to slow tumor development and used pharmacological inhibition of extracellular peroxidases to improve overall survival in breast cancer models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357145,1790337834,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","iScience Article  \nStromal peroxidasin drives early tumor growth in breast cancer  \nAuthors  \nKaitlin Wyllie, Ellie T.Y. Mok, Que Emmi Tran,   , Amelia L. Parker, Vasilios Panagopoulos, Thomas R. Cox  \nCorrespondence  \n[bill.panagopoulos@adelaide.edu.au](bill.panagopoulos@adelaide.edu.au)[ ](bill.panagopoulos@adelaide.edu.au)(V.P.),  \n[t.cox@garvan.org.au](t.cox@garvan.org.au) (T.R.C.)  \nIn brief  \nMolecular biology; cell biology; cancer systems biology  \n• Peroxidasin expression peaks during early breast cancer development  \n• Cancer-associated fibroblasts are a major source of tumorpromoting peroxidasin  \n• Targeting extracellular peroxidases extends survival in breast cancer models  \nWyllie et al., 2026, iScience 29, 116078  \nJune 19, 2026 © 2026 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.isci.2026.116078](https://doi.org/10.1016/j.isci.2026.116078)  \nll  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nStromal peroxidasin drives early tumor growth in breast cancer  \nKaitlin Wyllie,1,2 Ellie T.Y. Mok,1,2 Que Emmi Tran,1 Elysse C. Filipe,1,2 Jessica L. Chitty,1,2 Ron Enriquez,1  \nAnaiis Zaratzian,1 Andrew M. Da Silva,1 Michael Tayao,1 David Gallego-Ortega,3 Sandra O’Toole,1,4 Amelia L. Parker,1,2 Vasilios Panagopoulos,5,* and Thomas R. Cox1,2,6,*  \n1The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, NSW, Australia  \n2School of Clinical Medicine, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia  \n3School of Biomedical Engineering, University of Technology, Sydney, NSW, Australia  \n4Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia  \n5Centre for Cancer Biology, College of Health, Adelaide University, Adelaide, SA, Australia  \n6Lead contact  \n*Correspondence: [bill.panagopoulos@adelaide.edu.au](bill.panagopoulos@adelaide.edu.au) (V. P.), [t.cox@garvan.org.au](t.cox@garvan.org.au) (T. R.C.) [https://doi.org/10.1016/j.isci.2026.116078](https://doi.org/10.1016/j.isci.2026.116078)  \nSUMMARY  \nThe extracellular matrix (ECM) plays multifaceted tumor-promoting and tumor-restraining roles in breast cancer progression. Extracellular peroxidases represent a critical yet underexplored component of stromal remodeling machinery. Peroxidasin (PXDN), an extracellular peroxidase with established roles in collagen IV crosslinking, has been associated with poor outcomes in several cancers, but its role in breast cancer remains unclear. Through temporal proteomic analysis of dysregulated ECM proteins, we identified PXDNas upregulated during early tumor development in mouse models. In human breast cancers, PXDN expression shows compartment-specific associations with patient outcome, with high stromal PXDN, predominantly cancer-associated fibroblast (CAF)-derived, correlating with poor prognosis. We demonstrate that PXDN regulates CAF behavior, with subsequent matrix remodeling affecting cancer cell behavior. Reduction of CAF-derived PXDNin vivo slows tumor development, while pharmacological inhibition of extracellular peroxidases improves overall survival. These findings establish PXDN as a mediator of breast tumor progression and a promising future therapeutic target.  \nINTRODUCTION  \nBreast cancer is the most prevalent cancer among women worldwide and remains the leading cause of cancer-related mortality for women.1 ,2 Despite significant advancements in early detection and rates of surgical resection over recent decades leading to relatively high 5-year survival rates for stage I and II breast cancer patients (85%–90%), this survival drops dramatically to around 29% for patients with stage IV disease.3 Moreover, recurrence remains a significant concern, affecting an estimated 12%–41% of patients.4–6 These statistics highlight the need to improve current treatments for these patients.  \nOne major contributor to poor outcomes in breast cancer is thought to be th","cbCaiqPenIQ3mJ73","https://ap.wps.com/l/cbCaiqPenIQ3mJ73","pdf",12595004,25,"English","# Summary\n# Introduction\n# Results\n## Peroxidasin expression during early development\n## CAF-derived PXDN and patient outcomes\n## Targeting extracellular peroxidases for survival","[{\"question\":\"What role does peroxidasin (PXDN) play in early breast cancer development?\",\"answer\":\"Temporal proteomic analysis shows PXDN is upregulated during early tumor development in mouse models, indicating a role in initiating stromal changes that support tumor growth.\"},{\"question\":\"How is PXDN linked to prognosis in human breast cancer?\",\"answer\":\"Human data show compartment-specific associations, with high stromal PXDN—predominantly derived from cancer-associated fibroblasts—correlating with poor prognosis.\"},{\"question\":\"What therapeutic strategies did the study test targeting PXDN-related pathways?\",\"answer\":\"The study reduced CAF-derived PXDN in vivo to slow tumor development and used pharmacological inhibition of extracellular peroxidases to improve overall survival in breast cancer models.\"}]","Stromal Peroxidasin Drives Early Tumor Growth in Breast Cancer | PDF",1790129133,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec6c053b3958b9544f3d8f407c892bfe.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6d6e3d1e09c762268948b8e46dc5e3d.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0affa3f53f5788a831afe7f9b4a92bbb.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1534cc5845c70d6a0dbe87db3da085f0.webp",980,1272]